Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer

Adam S. Garden; Jonathan Harris; Avraham Eisbruch; K. S.Clifford Chao; William H. Morrison; Paul M. Harari; Todd Allen Swanson; Christopher U. Jones; Sue S. Yom; Sharon A. Spencer; Rufus Scrimger; George Shenouda; Monica Shukla; Harold Y. Lau; Michelle Mierzwa; Pedro Torres-Saavedra; Quynh Thu Le

doi:10.1016/j.ijrobp.2023.02.057

Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer

Adam S. Garden, Jonathan Harris, Avraham Eisbruch, K. S.Clifford Chao, William H. Morrison, Paul M. Harari, Todd Allen Swanson, Christopher U. Jones, Sue S. Yom, Sharon A. Spencer, Rufus Scrimger, George Shenouda, Monica Shukla, Harold Y. Lau, Michelle Mierzwa, Pedro Torres-Saavedra, Quynh Thu Le

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	333-340
Number of pages	8
Journal	International Journal of Radiation Oncology Biology Physics
Volume	117
Issue number	2
DOIs	https://doi.org/10.1016/j.ijrobp.2023.02.057
State	Published - Oct 1 2023

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/j.ijrobp.2023.02.057

Cite this

Garden, A. S., Harris, J., Eisbruch, A., Chao, K. S. C., Morrison, W. H., Harari, P. M., Swanson, T. A., Jones, C. U., Yom, S. S., Spencer, S. A., Scrimger, R., Shenouda, G., Shukla, M., Lau, H. Y., Mierzwa, M., Torres-Saavedra, P., & Le, Q. T. (2023). Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. International Journal of Radiation Oncology Biology Physics, 117(2), 333-340. https://doi.org/10.1016/j.ijrobp.2023.02.057

Garden, AS, Harris, J, Eisbruch, A, Chao, KSC, Morrison, WH, Harari, PM, Swanson, TA, Jones, CU, Yom, SS, Spencer, SA, Scrimger, R, Shenouda, G, Shukla, M, Lau, HY, Mierzwa, M, Torres-Saavedra, P & Le, QT 2023, 'Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer', International Journal of Radiation Oncology Biology Physics, vol. 117, no. 2, pp. 333-340. https://doi.org/10.1016/j.ijrobp.2023.02.057

@article{2a5cf3d228494b3c8e7c7c57e29e25ae,

title = "Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer",

author = "Garden, {Adam S.} and Jonathan Harris and Avraham Eisbruch and Chao, {K. S.Clifford} and Morrison, {William H.} and Harari, {Paul M.} and Swanson, {Todd Allen} and Jones, {Christopher U.} and Yom, {Sue S.} and Spencer, {Sharon A.} and Rufus Scrimger and George Shenouda and Monica Shukla and Lau, {Harold Y.} and Michelle Mierzwa and Pedro Torres-Saavedra and Le, {Quynh Thu}",

note = "Funding Information: Disclosures: Q.T.L. reports support for attending meetings and/or travel from the Radiation Therapy Oncology Group (RTOG) Foundation and a leadership role as RTOG group chair (NRG Oncology). M.M. reports that Bristol-Myers Squibb supplied drugs for clinical trial UMCC 2018.085. In addition, she received academic support from Debio and holds a leadership role with the International Journal of Radiation Oncology • Biology • Physics as associate editor for the head and neck section. P.T.-S. reports support for the present article from NRG Oncology SDMC and the grant from the National Cancer Institute. S.S.Y. reports grants or contracts paid to her institution for research support from Genentech, BioMimetix, Merck, EMD Serono, and Bristol-Myers Squibb; royalties or licenses from UpToDate and Springer; and payment or honoraria for lectures or presentations from the American Society for Radiation Oncology and Elsevier. She is also a past president of the American Radium Society. The remaining authors have no disclosures to report. Funding Information: This project was supported by grants U10CA180868 ( NRG Oncology Operations ), U10CA180822 (NRG Oncology Statistical and Data Management Center), and U24CA180803 (Imaging and Radiation Oncology Center) from the National Cancer Institute. ",

year = "2023",

month = oct,

day = "1",

doi = "10.1016/j.ijrobp.2023.02.057",

language = "English (US)",

volume = "117",

pages = "333--340",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Final Report of NRG Oncology RTOG 0022

T2 - A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer

AU - Garden, Adam S.

AU - Harris, Jonathan

AU - Eisbruch, Avraham

AU - Chao, K. S.Clifford

AU - Morrison, William H.

AU - Harari, Paul M.

AU - Swanson, Todd Allen

AU - Jones, Christopher U.

AU - Yom, Sue S.

AU - Spencer, Sharon A.

AU - Scrimger, Rufus

AU - Shenouda, George

AU - Shukla, Monica

AU - Lau, Harold Y.

AU - Mierzwa, Michelle

AU - Torres-Saavedra, Pedro

AU - Le, Quynh Thu

N1 - Funding Information: Disclosures: Q.T.L. reports support for attending meetings and/or travel from the Radiation Therapy Oncology Group (RTOG) Foundation and a leadership role as RTOG group chair (NRG Oncology). M.M. reports that Bristol-Myers Squibb supplied drugs for clinical trial UMCC 2018.085. In addition, she received academic support from Debio and holds a leadership role with the International Journal of Radiation Oncology • Biology • Physics as associate editor for the head and neck section. P.T.-S. reports support for the present article from NRG Oncology SDMC and the grant from the National Cancer Institute. S.S.Y. reports grants or contracts paid to her institution for research support from Genentech, BioMimetix, Merck, EMD Serono, and Bristol-Myers Squibb; royalties or licenses from UpToDate and Springer; and payment or honoraria for lectures or presentations from the American Society for Radiation Oncology and Elsevier. She is also a past president of the American Radium Society. The remaining authors have no disclosures to report. Funding Information: This project was supported by grants U10CA180868 ( NRG Oncology Operations ), U10CA180822 (NRG Oncology Statistical and Data Management Center), and U24CA180803 (Imaging and Radiation Oncology Center) from the National Cancer Institute.

PY - 2023/10/1

Y1 - 2023/10/1

UR - http://www.scopus.com/inward/record.url?scp=85152420386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152420386&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2023.02.057

DO - 10.1016/j.ijrobp.2023.02.057

M3 - Article

C2 - 36925074

AN - SCOPUS:85152420386

SN - 0360-3016

VL - 117

SP - 333

EP - 340

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 2

ER -

Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this